LCM
SPPI

Laurion Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Laurion Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-60,619
Closed -$47K – 640
2022
Q2 		$47K Buy
+60,619
New +$53.4K ﹤0.01% 430
2019
Q3 		– Sell
-75,708
Closed -$652K – 1344
2019
Q2 		$652K Buy
+75,708
New +$677K 0.01% 646
2018
Q3 		– Sell
-20,877
Closed -$438K – 1619
2018
Q2 		$438K Buy
+20,877
New +$387K ﹤0.01% 999

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Laurion Capital Management's SPPI Position: Q3 2022 in Review

Laurion Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 60,619 shares — an estimated $47K sold.

Laurion Capital Management first reported a position in SPPI in Q2 2018 and held it in 3 quarters. The position peaked at $652K in Q2 2019. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.

  • Laurion Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
  • Laurion Capital Management sold 60,619 Spectrum Pharmaceuticals Inc shares in Q3 2022, an estimated $47K.
  • Laurion Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2018 and held it in 3 quarters.
  • Laurion Capital Management's Spectrum Pharmaceuticals Inc position peaked at $652K in Q2 2019.
  • 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.

Based on Laurion Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.